Compounds > chloroquine

chloroquine and chitosan

chloroquine has been researched along with chitosan in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's9 (81.82)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
August, JT; Janes, KA; Leong, KW; Lin, KY; Mao, HQ; Roy, K; Troung-Le, VL; Wang, Y1
Astolfi, M; Buschmann, MD; Darras, V; Lavertu, M; Merzouki, A; Thibault, M; Tran-Khanh, N1
Chakraborty, SP; Das, S; Pramanik, P; Roy, S; Sahu, SK; Tripathy, S1
Chattopadhyay, S; Das, S; Dash, SK; Mahapatra, SK; Majumder, S; Pramanik, P; Roy, S; Tripathy, S1
Chattopadhyay, S; Das, S; Dash, SK; Mahapatra, SK; Majumdar, S; Roy, S; Tripathy, S1
Chattopadhyay, S; Chowdhuri, AR; Das, S; Dash, SK; Majumdar, S; Roy, S; Sahu, SK; Tripathy, S1
Chang, J; Shi, Y; Su, C; Yang, G; Zhao, L1
Abreu, CM; de Paula, RC; Feitosa, JP; Goycoolea, FM; Magalhães, GA; Moura Neto, E; Paula, HC; Richter, AR; Sombra, VG1
Astolfi, M; Buschmann, MD; Lavertu, M; Thibault, M1
Shi, Y; Su, C; Zhao, L; Zheng, Y1
Das, S; Pramanik, P; Roy, S; Saha, B; Tripathy, S1

Other Studies

11 other study(ies) available for chloroquine and chitosan

ArticleYear
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
    Journal of controlled release : official journal of the Controlled Release Society, 2001, Feb-23, Volume: 70, Issue:3

    Topics: Animals; Cell Line; Chitin; Chitosan; Chloroquine; DNA; Genetic Therapy; Humans; Mice; Mice, Inbred AKR; Polyethylene Glycols; Tissue Distribution; Transfection

2001
Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes.
    Biomaterials, 2011, Volume: 32, Issue:20

    Topics: Antimalarials; Chitosan; Chloroquine; DNA; Gene Transfer Techniques; Genetic Therapy; HEK293 Cells; Humans; Lysosomes; Materials Testing; Polyamines; Polyelectrolytes; Transfection

2011
Synthesis, characterization of chitosan-tripolyphosphate conjugated chloroquine nanoparticle and its in vivo anti-malarial efficacy against rodent parasite: a dose and duration dependent approach.
    International journal of pharmaceutics, 2012, Sep-15, Volume: 434, Issue:1-2

    Topics: Animals; Antimalarials; Chitosan; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Malaria; Male; Mice; Nanoparticles; Plasmodium berghei; Polyphosphates; Time Factors

2012
A novel chitosan based antimalarial drug delivery against Plasmodium berghei infection.
    Acta tropica, 2013, Volume: 128, Issue:3

    Topics: Animals; Antimalarials; Chitosan; Chloroquine; Disease Models, Animal; DNA Damage; Drug Carriers; Drug Delivery Systems; Malaria; Mice; Oxidative Stress; Parasitemia; Plasmodium berghei; Treatment Outcome

2013
A prospective strategy to restore the tissue damage in malaria infection: Approach with chitosan-trypolyphosphate conjugated nanochloroquine in Swiss mice.
    European journal of pharmacology, 2014, Aug-15, Volume: 737

    Topics: Animals; Antimalarials; Antioxidants; Biomarkers; Catalase; Cell Death; Chitosan; Chloroquine; Cytokines; DNA Damage; Glutathione; Liver; Malaria; Male; Mice; Nanoparticles; Oxidative Stress; Particle Size; Plasmodium berghei; Polyphosphates; Prospective Studies; Spleen; Superoxide Dismutase

2014
Chitosan conjugated chloroquine: proficient to protect the induction of liver apoptosis during malaria.
    International journal of biological macromolecules, 2015, Volume: 74

    Topics: Animals; Antimalarials; Apoptosis; Caspase 3; Caspase 9; Chitosan; Chloroquine; Drug Carriers; Glutathione; Lipid Peroxidation; Liver; Malaria; Materials Testing; Membrane Potential, Mitochondrial; Mice; Nanoparticles; Parasitemia; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared

2015
Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.
    Journal of nanobiotechnology, 2015, Sep-22, Volume: 13

    Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Fluorescein-5-isothiocyanate; Gefitinib; Humans; Intracellular Space; Nanoparticles; Necrosis; Quinazolines

2015
Chitosan/Sterculia striata polysaccharides nanocomplex as a potential chloroquine drug release device.
    International journal of biological macromolecules, 2016, Volume: 88

    Topics: Chitosan; Chloroquine; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Karaya Gum; Molecular Weight; Nanoparticles; Particle Size; Static Electricity; Sterculia

2016
Structure Dependence of Lysosomal Transit of Chitosan-Based Polyplexes for Gene Delivery.
    Molecular biotechnology, 2016, Volume: 58, Issue:10

    Topics: Cell Survival; Chitosan; Chloroquine; DNA; Gene Transfer Techniques; HEK293 Cells; Humans; Lysosomes; Macrolides; Materials Testing; Transfection

2016
mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy.
    Journal of nanobiotechnology, 2017, Oct-04, Volume: 15, Issue:1

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Cell Line, Tumor; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Nanoparticles; Neoplasms; Protein Kinase Inhibitors; Quinazolines

2017
A novel nano-anti-malarial induces redox damage and elicits cytokine response to the parasite.
    Cytokine, 2021, Volume: 144

    Topics: Animals; Antimalarials; Cells, Cultured; Chitosan; Chloroquine; Cytokines; Drug Resistance; Humans; Inflammation; Leukocytes, Mononuclear; Malaria; Nanoparticles; Oxidation-Reduction; Parasites; Plasmodium falciparum

2021